Logo image of CNVY

Convey Health Solutions Holdings Inc (CNVY) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CNVY - US21258C1080 - Common Stock

10.51 USD
-0.05 (-0.47%)
Last: 10/6/2022, 8:04:00 PM
10.51 USD
0 (0%)
After Hours: 10/6/2022, 8:04:00 PM
Fundamental Rating

2

CNVY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of CNVY have multiple concerns. CNVY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CNVY had negative earnings in the past year.
CNVY Yearly Net Income VS EBIT VS OCF VS FCFCNVY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 10M -10M 20M 30M

1.2 Ratios

Industry RankSector Rank
ROA -0.76%
ROE N/A
ROIC 1.87%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVY Yearly ROA, ROE, ROICCNVY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 1 -1 2 -2

1.3 Margins

Industry RankSector Rank
OM 5.47%
PM (TTM) -1.9%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNVY Yearly Profit, Operating, Gross MarginsCNVY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNVY is destroying value.
  • Compared to 1 year ago, CNVY has more shares outstanding
  • The debt/assets ratio for CNVY has been reduced compared to a year ago.
CNVY Yearly Shares OutstandingCNVY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M
CNVY Yearly Total Debt VS Total AssetsCNVY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.68, we must say that CNVY is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.50 indicates that CNVY is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 1.68
ROIC/WACC0.18
WACC10.35%
CNVY Yearly LT Debt VS Equity VS FCFCNVY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • CNVY has a Current Ratio of 2.20. This indicates that CNVY is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 1.60 indicates that CNVY should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.6
CNVY Yearly Current Assets VS Current LiabilitesCNVY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

  • CNVY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.74%, which is quite impressive.
  • Looking at the last year, CNVY shows a quite strong growth in Revenue. The Revenue has grown by 16.45% in the last year.
  • CNVY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.55% yearly.
EPS 1Y (TTM)28.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)16.45%
Revenue growth 3Y23.55%
Revenue growth 5YN/A
Sales Q2Q%19.31%

3.2 Future

  • CNVY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 91.65% yearly.
  • Based on estimates for the next years, CNVY will show a quite strong growth in Revenue. The Revenue will grow by 15.76% on average per year.
EPS Next Y406.25%
EPS Next 2Y171.28%
EPS Next 3Y119.84%
EPS Next 5Y91.65%
Revenue Next Year19.05%
Revenue Next 2Y17.57%
Revenue Next 3Y16.68%
Revenue Next 5Y15.76%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CNVY Yearly Revenue VS EstimatesCNVY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
CNVY Yearly EPS VS EstimatesCNVY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CNVY. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 24.03, the valuation of CNVY can be described as rather expensive.
  • When comparing the Price/Forward Earnings ratio of CNVY to the average of the S&P500 Index (24.26), we can say CNVY is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 24.03
CNVY Price Earnings VS Forward Price EarningsCNVY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.33
CNVY Per share dataCNVY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CNVY's earnings are expected to grow with 119.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y171.28%
EPS Next 3Y119.84%

More info and screens

0

5. Dividend

5.1 Amount

  • CNVY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Convey Health Solutions Holdings Inc

NYSE:CNVY (10/6/2022, 8:04:00 PM)

After market: 10.51 0 (0%)

10.51

-0.05 (-0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-12
Earnings (Next)11-09
Inst Owners0.11%
Inst Owner Change0%
Ins Owners1.08%
Ins Owner Change0%
Market Cap769.56M
Revenue(TTM)366.21M
Net Income(TTM)-6.95M
Analysts48.89
Price Target11.22 (6.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.03
P/S 2.1
P/FCF N/A
P/OCF N/A
P/B 1.45
P/tB N/A
EV/EBITDA 19.33
EPS(TTM)-0.1
EYN/A
EPS(NY)0.44
Fwd EY4.16%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5
BVpS7.25
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.76%
ROE N/A
ROCE N/A
ROIC 1.87%
ROICexc N/A
ROICexgc 12.86%
OM 5.47%
PM (TTM) -1.9%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 1.6
Altman-Z 1.68
F-Score6
WACC10.35%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y406.25%
EPS Next 2Y171.28%
EPS Next 3Y119.84%
EPS Next 5Y91.65%
Revenue 1Y (TTM)16.45%
Revenue growth 3Y23.55%
Revenue growth 5YN/A
Sales Q2Q%19.31%
Revenue Next Year19.05%
Revenue Next 2Y17.57%
Revenue Next 3Y16.68%
Revenue Next 5Y15.76%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Convey Health Solutions Holdings Inc / CNVY FAQ

What is the ChartMill fundamental rating of Convey Health Solutions Holdings Inc (CNVY) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CNVY.


Can you provide the valuation status for Convey Health Solutions Holdings Inc?

ChartMill assigns a valuation rating of 3 / 10 to Convey Health Solutions Holdings Inc (CNVY). This can be considered as Overvalued.


How profitable is Convey Health Solutions Holdings Inc (CNVY) stock?

Convey Health Solutions Holdings Inc (CNVY) has a profitability rating of 4 / 10.


What is the earnings growth outlook for Convey Health Solutions Holdings Inc?

The Earnings per Share (EPS) of Convey Health Solutions Holdings Inc (CNVY) is expected to grow by 406.25% in the next year.